This Project Grant award from the National Institute of Mental Health (CFDA 93.242 - Mental Health Research Grants) provides $729,367 to The RAND Corporation to study the impacts of a prescription stimulant shortage on youth with Attention-Deficit Hyperactivity Disorder (ADHD). Specifically, the project will: Construct community-level measures of stimulant medication shortages and assess their relationship with demographic, socioeconomic, and healthcare characteristics. Evaluate whether youth in communities affected by the stimulant shortage experienced differential trends in ADHD, mental health, and substance use disorder treatment. Investigate treatment process, mental health, substance use, and educational consequences for ADHD patients whose treatment was interrupted by the shortage. Determine if there were disparate impacts based on patient race/ethnicity, urbanicity, prescriber specialty, and school/community characteristics. The project aims to provide rigorous evidence on the health and non-health impacts of prescription drug shortages on vulnerable populations, which can inform regulators on mitigating the effects of supply disruptions. The award period runs from December 2024 through November 2028.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $729.4k | 12/18/24 |